<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Life Sciences</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/C7EF6EFD-C23E-48FB-A542-CB891A4B5456"><gtr:id>C7EF6EFD-C23E-48FB-A542-CB891A4B5456</gtr:id><gtr:firstName>Stuart</gtr:firstName><gtr:otherNames>Michael</gtr:otherNames><gtr:surname>Haslam</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/A8DF9FEB-45F9-4739-9F82-4211925B08D9"><gtr:id>A8DF9FEB-45F9-4739-9F82-4211925B08D9</gtr:id><gtr:firstName>Howard</gtr:firstName><gtr:otherNames>Redfern</gtr:otherNames><gtr:surname>Morris</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/13E7100E-9353-40BF-B963-627557C30116"><gtr:id>13E7100E-9353-40BF-B963-627557C30116</gtr:id><gtr:firstName>Anne</gtr:firstName><gtr:surname>Dell</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=BB%2FK016164%2F1"><gtr:id>7DE76229-BC25-41D5-A561-8ABFCA0B5E76</gtr:id><gtr:title>Core Support for Collaborative Research in Glycobiology</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/K016164/1</gtr:grantReference><gtr:abstractText>The genome sequencing projects of the past two decades have yielded the startling revelation that the total number of genes in humans is not very different from many model organisms such as worms and plants. This discovery served to highlight the fact that substantial amplification of genomic information occurs after genes are translated into proteins. Glycosylation, which involves the addition of sugars to selected protein amino acid side-chains, is the most abundant and arguably the most important of these post-translational modifications. Indeed, all cells are coated with a sugar-rich layer called the glycocalyx. Chains of sugars, called glycans, on the periphery of the glycocalyx bind to specific sugar-recognition proteins, called lectins, on partner cells. Many important biological processes depend on the ability of cells to appropriately communicate with each other via these sugar-lectin interactions and to respond accordingly. For example, lectins on the surfaces of viruses and bacteria are known to recognise sugars on target cells and attach to them as the first step of infection. Conversely the adaptive immune system is triggered when sugars on the surfaces of pathogens bind to lectins expressed by cells of the host immune system. Although these examples of glycan-lectin recognition are now relatively well understood, many biological processes that are likely to be similarly controlled by glycan-lectin interactions remain enigmatic. For example, how do immune cells in the gut distinguish between beneficial and harmful microbes, and how does a developing foetus escape rejection by the mother despite being half &amp;quot;foreign&amp;quot;? Pivotal to learning how glycans function in these processes is knowing their structures. We specialize in glycan structural determination using a sophisticated analytical technique called mass spectrometry. We do this in collaboration with dozens of scientists from many biological disciplines both nationally and internationally, who are working with us to explore glycan-lectin structure/function relationships. We are particularly interested in characterizing the glycans that are involved in host microbe interactions, in immune regulation and in mediating recognition events during mammalian reproduction. As well as contributing to fundamental understanding of glycan function, we aim to provide structural data to underpin the identification of targets for new drugs and vaccines for the control of pathogens and parasites. We anticipate that our studies of the glycobiology of mammalian fertilization and reproduction will open up new avenues for natural contraception as well as helping infertile couples. Another of our goals is to understand the pathways involved in regulating glycosylation. This is important, not only because altered glycosylation is associated with many chronic health and aging problems, but also because this knowledge will assist the efficient production of well defined glycoprotein biopharmaceuticals. As well as being important constituents of glycoproteins, sugars are the major building blocks of the polysaccharides that constitute the walls of plant cells. There is an urgent need to better understand the biological processes involved in plant cell wall assembly if the potential of biomass as a renewable energy resource and an alternative to fossil fuels for the production of high value chemicals is to be fully realised. We aim to work with plant scientists in the UK and Australia to elucidate the molecular mechanisms of cell wall polysaccharide biosynthesis. Our analytical methods generate large volumes of complex data, so another of our objectives is to create glycoinformatic tools to assist and speed up data interpretation and annotation, and these tools will be made available to the scientific community. We will also develop and populate openly available databases with our glycan structural data, a resource that will benefit scientists from many disciplines around the world.</gtr:abstractText><gtr:technicalSummary>We request core support for our world-class mass spectrometry laboratory to enable us to continue to undertake glycobiological research of relevance to the BBSRC priority areas of basic bioscience underpinning health, food security and bioenergy. We are working with more than thirty collaborators in the UK and abroad with the overarching goal of providing a molecular understanding of (i) biological events in which glycan-lectin recognition plays a central role, and (ii) regulation of glycosylation pathways in the biosynthesis of eukaryotic and prokaryotic glycoproteins, bacterial lipopolysaccharides and plant cell wall polysaccharides. A key objective of our research is the continued enhancement of our glycomic and glycoproteomic platforms which are based on the integration of ultra-high sensitivity mass spectrometry with carbohydrate and protein chemistry. We aim to continue to develop open source informatic tools for improving data analysis and to substantially improve and populate public data resources. We will apply our technologies to projects in the following areas: (a) the glycobiology of host/pathogen interactions including characterising glycoconjugates of pathogens and parasites with an important aim being to identify potential vaccine candidates; (b) defining the roles of glycans in regulating host-virus interactions, including characterisation of viral glycoproteins as well as the glycan and lectin receptors of their hosts; (c) exploring how host glycosylation influences the gut microbiome thereby contributing to research into human nutrition and health; (d) investigating the regulation of mammalian glycosylation via the study of metabolic dysfunction; (e) contributing to the glycobiology of mammalian fertilization and reproduction including hunting for the egg binding protein on human sperm and defining structure/function relationships in glycodelin glycoforms; (f) defining the molecular mechanisms of cell wall polysaccharide assembly in higher plants.</gtr:technicalSummary><gtr:potentialImpactText>The programme of work outlined in this proposal will have considerable academic, economic and societal impact. It will not only lead to new knowledge and scientific advancement for the numerous collaborating scientists detailed in the proposal, but will benefit the wider academic community who have interests in cell-cell interactions, pathogen virulence, immune suppression, adaptive immunity, health and nutrition, the gut microbiome, human fertilization and reproduction, metabolic disorders, bioprocessing and plant sciences. Non-academic beneficiaries of our research will include the biotech and pharma industries, plus the biofuels and industrial biotechnology sectors. Other beneficiaries are the Animal Health and Veterinary Laboratories Agency, who will exploit our research outputs to improve their assays for diagnosis of porcine and bovine brucellosis, and the Defence Science and Technology Laboratory, whose vaccine programmes will benefit from our enhanced methodologies for bacterial LPS analysis. Many of the BBSRC's priority areas have an urgent need for glycobiological skills. We will address this issue by training and delivering highly skilled glycobiology researchers in our GlycoTRIC Centre. We will continue to develop and improve glycomic and glycoproteomic technologies, especially our glycoinformatic tools and data depositories, which will lead to worldwide academic advancements. Our research will give outputs that will benefit and impact on society in general. For example our studies of the glycobiology of host/pathogen interactions will lead to the development of new treatments and vaccines against a wide range of human and animal diseases which will lead to better human and animal health and an improved quality of life and food security. Our studies of the glycobiology of mammalian fertilization and reproduction will assist women suffering from infertility and recurrent pregnancy loss and potentially also have an impact on livestock production. Our studies of plant cell wall biosynthesis will provide a better fundamental understanding of the processes involved and therefore facilitate the exploitation of biomass for the production of biofuels and high value chemicals. Outputs from our glycomic and glycoproteomic method development will have an impact on UK and international industry therefore contributing towards wealth creation and economic prosperity. Our research on defining post-translational modifications of proteins is of special interest to both the pharma and biotech industries, not least because of the importance of glycosylation in many therapeutic proteins currently under development. Our mass spectrometric method development has been pioneering, and a number of our original discoveries including the concept of MS peptide and glycopeptide mapping now feature in the International Committee on Harmonisation (ICH) Guidelines for Test Procedures and Acceptance Criteria for Biotechnology Products and in the Points to Consider advice on Characterising Monclonal Antibodies, thus accelerating and simplifying the characterisation of Biopharmaceutical Products with considerable financial implications of benefit to industry and to the end-consumer in society. Our research outputs will benefit MS instrument manufacturers in the UK and abroad. Such companies can exploit our glycoinformatics developments by incorporating the tools we design into their commercial analysis platforms, benefiting from reduced development costs and increased sales as a result of the new features gained. Bruker Daltronics recently benefited in this way by incorporating our GlycoWorkbench tool into their commercial software.</gtr:potentialImpactText><gtr:fund><gtr:end>2017-06-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2013-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1410325</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Multiple school visits and open days</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A9ED1FA4-B87D-4E1D-9CDF-DB1EB33935E4</gtr:id><gtr:impact>Multiple visits to state schools under the Speakers for Schools scheme giving talks to groups of 50-100 pupils. Open days at Imperial College involving over a hundred students, teachers and parents.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013,2014,2015,2016,2017</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1728000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Responsive mode</gtr:description><gtr:end>2017-06-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/K016164/1</gtr:fundingRef><gtr:id>4E96BA30-12B8-43A1-8483-72FF7D3D2490</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2013-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4281288</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>sLoLa</gtr:description><gtr:end>2021-03-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/N001591/1</gtr:fundingRef><gtr:id>C7FC4176-4CDB-4ED0-BF90-C643CF20E893</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>An interactive outreach demonstration kit has been developed by postdoctoral staff employed on this grant illustrating our sperm-egg binding research and has been used to engage the public at a Royal Society Summer Exhibition and the BBSRC's Great British Bioscience Festival, as well as in schools.</gtr:description><gtr:firstYearOfImpact>2013</gtr:firstYearOfImpact><gtr:id>3FF792BA-F4DA-4E4D-88BD-DAF0088D6F5F</gtr:id><gtr:impactTypes><gtr:impactType>Societal</gtr:impactType></gtr:impactTypes><gtr:sector>Education,Culture, Heritage, Museums and Collections</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>Major achievements include: (1) via our collaborations with bioscientists worldwide we are opening up new fields of glycobiology; (2) we are developing improved analytical glycomic and glycoproteomic methodologies; and (3) we are disseminating know-how and expertise via the training activities of our glycoTRIC Centre. Our structural outputs from over fifty collaborations have yielded new understanding of glycan involvement in pathogen infection and self/non-self recognition in human reproduction, as well as contributing to the development of global glycosylation inhibitors which have tharapeutic potential.</gtr:description><gtr:exploitationPathways>All our research outputs are being exploited by our collaborators to push forward their own research.
Global glycosylation inhibitors could potentially treat diseases such as autoimmunity, cancer metastasis and influenza.
Our pathogen research is facilitating the glyco-engineering of glycoconjugate vaccines.</gtr:exploitationPathways><gtr:id>4FA49ED5-5C0A-43D9-8BD9-655EB9AA5121</gtr:id><gtr:sectors><gtr:sector>Agriculture, Food and Drink,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7F4E77D5-3301-47C1-96ED-3A5E5B3C343D"><gtr:id>7F4E77D5-3301-47C1-96ED-3A5E5B3C343D</gtr:id><gtr:title>GlyTouCan 1.0--The international glycan structure repository.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/35b59900d1465b4747600a1b16906afe"><gtr:id>35b59900d1465b4747600a1b16906afe</gtr:id><gtr:otherNames>Aoki-Kinoshita K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/446BFF16-3328-4E45-A55D-90DC9518C291"><gtr:id>446BFF16-3328-4E45-A55D-90DC9518C291</gtr:id><gtr:title>Synthesis of biologically active N- and O-linked glycans with multisialylated poly-N-acetyllactosamine extensions using P. damsela a2-6 sialyltransferase.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1bf4d92f32912584929e8e4acc0ba906"><gtr:id>1bf4d92f32912584929e8e4acc0ba906</gtr:id><gtr:otherNames>Nycholat CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B7DFF173-ACF3-41A3-94E6-82727C00F5AA"><gtr:id>B7DFF173-ACF3-41A3-94E6-82727C00F5AA</gtr:id><gtr:title>Enhanced Aromatic Sequons Increase Oligosaccharyltransferase Glycosylation Efficiency and Glycan Homogeneity.</gtr:title><gtr:parentPublicationTitle>Chemistry &amp; biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/616ae5e0cd222f199fb7646832fb8d93"><gtr:id>616ae5e0cd222f199fb7646832fb8d93</gtr:id><gtr:otherNames>Murray AN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1074-5521</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5A8340BA-0596-4B95-88B5-346A7DEA2988"><gtr:id>5A8340BA-0596-4B95-88B5-346A7DEA2988</gtr:id><gtr:title>The highly conserved domain of unknown function 1792 has a distinct glycosyltransferase fold.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1bde23452702f3d087e5f35cb87dd0e1"><gtr:id>1bde23452702f3d087e5f35cb87dd0e1</gtr:id><gtr:otherNames>Zhang H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/46A40BB5-B17D-41E3-8850-325BF14BDB28"><gtr:id>46A40BB5-B17D-41E3-8850-325BF14BDB28</gtr:id><gtr:title>Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/159a3b019ba5649f3798bde79a63d648"><gtr:id>159a3b019ba5649f3798bde79a63d648</gtr:id><gtr:otherNames>Sassi A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/711B7EDC-5E1B-4AC4-BBC9-AAD3AE537718"><gtr:id>711B7EDC-5E1B-4AC4-BBC9-AAD3AE537718</gtr:id><gtr:title>Unique, polyfucosylated glycan-receptor interactions are essential for regeneration of Hydra magnipapillata.</gtr:title><gtr:parentPublicationTitle>ACS chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9982963875fe331ef588c2c43140b0fb"><gtr:id>9982963875fe331ef588c2c43140b0fb</gtr:id><gtr:otherNames>Sahadevan S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1554-8929</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A44D4883-4760-48CF-AC79-4D0AF29A5EEE"><gtr:id>A44D4883-4760-48CF-AC79-4D0AF29A5EEE</gtr:id><gtr:title>Role of Glycosyltransferases Modifying Type B Flagellin of Emerging Hypervirulent Clostridium difficile Lineages and Their Impact on Motility and Biofilm Formation.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0ab28b4b910418c280e90dbd622aed40"><gtr:id>0ab28b4b910418c280e90dbd622aed40</gtr:id><gtr:otherNames>Valiente E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/42F3F2BA-5557-44CF-8F7D-C4050D056527"><gtr:id>42F3F2BA-5557-44CF-8F7D-C4050D056527</gtr:id><gtr:title>Symbol Nomenclature for Graphical Representations of Glycans.</gtr:title><gtr:parentPublicationTitle>Glycobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/133982b7af4f800f952e5206a321e7b0"><gtr:id>133982b7af4f800f952e5206a321e7b0</gtr:id><gtr:otherNames>Varki A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0959-6658</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5AE32A6D-8209-4702-A1E9-53D076C84EE7"><gtr:id>5AE32A6D-8209-4702-A1E9-53D076C84EE7</gtr:id><gtr:title>Global N-linked Glycosylation is Not Significantly Impaired in Myoblasts in Congenital Myasthenic Syndromes Caused by Defective Glutamine-Fructose-6-Phosphate Transaminase 1 (GFPT1).</gtr:title><gtr:parentPublicationTitle>Biomolecules</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/87baae63149e8384883159bbff301f14"><gtr:id>87baae63149e8384883159bbff301f14</gtr:id><gtr:otherNames>Chen Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2218-273X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CA3BF3DC-C97F-4129-A663-0886350ACB6C"><gtr:id>CA3BF3DC-C97F-4129-A663-0886350ACB6C</gtr:id><gtr:title>Characterization of H type 1 and type 1 N-acetyllactosamine glycan epitopes on ovarian cancer specifically recognized by the anti-glycan monoclonal antibody mAb-A4.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6ce6fd3a11c2d0434919c100d8b66f39"><gtr:id>6ce6fd3a11c2d0434919c100d8b66f39</gtr:id><gtr:otherNames>Choo M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1EAD000B-2301-4507-AFF0-8AADDB5C606F"><gtr:id>1EAD000B-2301-4507-AFF0-8AADDB5C606F</gtr:id><gtr:title>Glycosphingolipid synthesis inhibition limits osteoclast activation and myeloma bone disease.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6121fafd2bb9978b5d8f562a5f43a5a2"><gtr:id>6121fafd2bb9978b5d8f562a5f43a5a2</gtr:id><gtr:otherNames>Ersek A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/69075D90-96E4-4E74-956F-29FA5BD028C6"><gtr:id>69075D90-96E4-4E74-956F-29FA5BD028C6</gtr:id><gtr:title>MIRAGE: the minimum information required for a glycomics experiment.</gtr:title><gtr:parentPublicationTitle>Glycobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/639d910fe628e9fc3a59f3405854459b"><gtr:id>639d910fe628e9fc3a59f3405854459b</gtr:id><gtr:otherNames>York WS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0959-6658</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/86F462A8-63B7-42CC-8A65-7778F0C5B8AC"><gtr:id>86F462A8-63B7-42CC-8A65-7778F0C5B8AC</gtr:id><gtr:title>XBP1s Links the Unfolded Protein Response to the Molecular Architecture of Mature N-Glycans.</gtr:title><gtr:parentPublicationTitle>Chemistry &amp; biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/866560d03bccbffa6162d0d388ebbc14"><gtr:id>866560d03bccbffa6162d0d388ebbc14</gtr:id><gtr:otherNames>Dewal MB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1074-5521</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/46F2FF04-2B50-4313-9B79-6142C4969B24"><gtr:id>46F2FF04-2B50-4313-9B79-6142C4969B24</gtr:id><gtr:title>ST3Gal-4 is the primary sialyltransferase regulating the synthesis of E-, P-, and L-selectin ligands on human myeloid leukocytes.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/74066785fa3c29574f2d9e1f0f818a26"><gtr:id>74066785fa3c29574f2d9e1f0f818a26</gtr:id><gtr:otherNames>Mondal N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/37CC53B2-C77A-4B3D-9D8E-565079D5C31E"><gtr:id>37CC53B2-C77A-4B3D-9D8E-565079D5C31E</gtr:id><gtr:title>Profiling of glycan receptors for minute virus of mice in permissive cell lines towards understanding the mechanism of cell recognition.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/62202b5f1de1ba232d407c138d56ca33"><gtr:id>62202b5f1de1ba232d407c138d56ca33</gtr:id><gtr:otherNames>Halder S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/73BCA8C3-4100-499B-820A-E9884427800D"><gtr:id>73BCA8C3-4100-499B-820A-E9884427800D</gtr:id><gtr:title>Glycomic characterization of respiratory tract tissues of ferrets: implications for its use in influenza virus infection studies.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4d2b34f8b5a505872fbec25c0529b8e6"><gtr:id>4d2b34f8b5a505872fbec25c0529b8e6</gtr:id><gtr:otherNames>Jia N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A55DB301-1959-4FD6-A71D-C92E76280C53"><gtr:id>A55DB301-1959-4FD6-A71D-C92E76280C53</gtr:id><gtr:title>Mapping the complete glycoproteome of virion-derived HIV-1 gp120 provides insights into broadly neutralizing antibody binding.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/defe1d8b514ebfd6e61004fbd2b4e3d7"><gtr:id>defe1d8b514ebfd6e61004fbd2b4e3d7</gtr:id><gtr:otherNames>Panico M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/20516BA3-3A12-4C6F-AFDC-7282F7576A74"><gtr:id>20516BA3-3A12-4C6F-AFDC-7282F7576A74</gtr:id><gtr:title>Partial correction of neutrophil dysfunction by oral galactose therapy in glycogen storage disease type Ib.</gtr:title><gtr:parentPublicationTitle>International immunopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d7bec8d87222017a46c9fb2e29f64c7a"><gtr:id>d7bec8d87222017a46c9fb2e29f64c7a</gtr:id><gtr:otherNames>Letkemann R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1567-5769</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/598CAC18-E2A5-4DB1-8288-0D70DF3BC41D"><gtr:id>598CAC18-E2A5-4DB1-8288-0D70DF3BC41D</gtr:id><gtr:title>JAGN1 deficiency causes aberrant myeloid cell homeostasis and congenital neutropenia.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f6e3f5dc92da877eb16229b4b3aa7210"><gtr:id>f6e3f5dc92da877eb16229b4b3aa7210</gtr:id><gtr:otherNames>Boztug K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9BB60BFA-C3CE-4A78-AE40-2FFC537CC130"><gtr:id>9BB60BFA-C3CE-4A78-AE40-2FFC537CC130</gtr:id><gtr:title>Evidence for Differential Glycosylation of Trophoblast Cell Types.</gtr:title><gtr:parentPublicationTitle>Molecular &amp; cellular proteomics : MCP</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/87baae63149e8384883159bbff301f14"><gtr:id>87baae63149e8384883159bbff301f14</gtr:id><gtr:otherNames>Chen Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1535-9476</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EA0DCFAE-C534-493C-B5BC-FD87F8B5A4EC"><gtr:id>EA0DCFAE-C534-493C-B5BC-FD87F8B5A4EC</gtr:id><gtr:title>The use of surface immobilization of P-selectin glycoprotein ligand-1 on mesenchymal stem cells to facilitate selectin mediated cell tethering and rolling.</gtr:title><gtr:parentPublicationTitle>Biomaterials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f8ce08d97ea7b218f4d565db8b28520a"><gtr:id>f8ce08d97ea7b218f4d565db8b28520a</gtr:id><gtr:otherNames>Lo CY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0142-9612</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8AAEA617-66D5-4E3C-9006-2126270C9B77"><gtr:id>8AAEA617-66D5-4E3C-9006-2126270C9B77</gtr:id><gtr:title>The zebrafish galectins Drgal1-L2 and Drgal3-L1 bind in vitro to the infectious hematopoietic necrosis virus (IHNV) glycoprotein and reduce viral adhesion to fish epithelial cells.</gtr:title><gtr:parentPublicationTitle>Developmental and comparative immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7efd544e88016c1805a0b93a6db03e8a"><gtr:id>7efd544e88016c1805a0b93a6db03e8a</gtr:id><gtr:otherNames>Nita-Lazar M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0145-305X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/953AE5CB-45C0-4E9E-96EF-3D7BA09BAADD"><gtr:id>953AE5CB-45C0-4E9E-96EF-3D7BA09BAADD</gtr:id><gtr:title>Cellular O-Glycome Reporter/Amplification to explore O-glycans of living cells.</gtr:title><gtr:parentPublicationTitle>Nature methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8f64f36d434ad7c5e9590235764d7417"><gtr:id>8f64f36d434ad7c5e9590235764d7417</gtr:id><gtr:otherNames>Kudelka MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1548-7091</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/68A486BC-CF94-4A21-A200-FAB03B2FC83E"><gtr:id>68A486BC-CF94-4A21-A200-FAB03B2FC83E</gtr:id><gtr:title>The minimum information required for a glycomics experiment (MIRAGE) project: sample preparation guidelines for reliable reporting of glycomics datasets.</gtr:title><gtr:parentPublicationTitle>Glycobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/93e65e404b45008cb0948a55c3ebac2e"><gtr:id>93e65e404b45008cb0948a55c3ebac2e</gtr:id><gtr:otherNames>Struwe WB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0959-6658</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6B23688B-0093-4C3A-97C3-7B2AE1BE9766"><gtr:id>6B23688B-0093-4C3A-97C3-7B2AE1BE9766</gtr:id><gtr:title>Engineering and Dissecting the Glycosylation Pathway of a Streptococcal Serine-rich Repeat Adhesin.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3c9a7b0330e2e6621adc59be394895a9"><gtr:id>3c9a7b0330e2e6621adc59be394895a9</gtr:id><gtr:otherNames>Zhu F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0AB216AF-B57D-439D-A020-2A349E933E9D"><gtr:id>0AB216AF-B57D-439D-A020-2A349E933E9D</gtr:id><gtr:title>Towards controlling the glycoform: a model framework linking extracellular metabolites to antibody glycosylation.</gtr:title><gtr:parentPublicationTitle>International journal of molecular sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c6bef48bedbfce62a25ee0e4117ca9cc"><gtr:id>c6bef48bedbfce62a25ee0e4117ca9cc</gtr:id><gtr:otherNames>Jedrzejewski PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1422-0067</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F7E995DD-BF7C-431C-AF88-060E8976734A"><gtr:id>F7E995DD-BF7C-431C-AF88-060E8976734A</gtr:id><gtr:title>Bovine Herpesvirus 4 Modulates Its ?-1,6-N-Acetylglucosaminyltransferase Activity through Alternative Splicing.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dbcde25aa7a106f9c49a0a9e6c9ff53e"><gtr:id>dbcde25aa7a106f9c49a0a9e6c9ff53e</gtr:id><gtr:otherNames>L?t? C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FB7DE320-D967-4CB1-92E1-5D759AF3A36D"><gtr:id>FB7DE320-D967-4CB1-92E1-5D759AF3A36D</gtr:id><gtr:title>Golgi self-correction generates bioequivalent glycans to preserve cellular homeostasis.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/70c41f82cbd0950f3b4fa0d4e56dceaa"><gtr:id>70c41f82cbd0950f3b4fa0d4e56dceaa</gtr:id><gtr:otherNames>Mkhikian H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CCEC2CA5-901F-4362-B17D-A514E0DF98BA"><gtr:id>CCEC2CA5-901F-4362-B17D-A514E0DF98BA</gtr:id><gtr:title>The human fetoembryonic defense system hypothesis: Twenty years on.</gtr:title><gtr:parentPublicationTitle>Molecular aspects of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b18d90719a288f062181ea1c09fea165"><gtr:id>b18d90719a288f062181ea1c09fea165</gtr:id><gtr:otherNames>Pang PC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0098-2997</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A500C1AA-BB57-4409-9ABD-E5CFC00A0388"><gtr:id>A500C1AA-BB57-4409-9ABD-E5CFC00A0388</gtr:id><gtr:title>Systemic blockade of sialylation in mice with a global inhibitor of sialyltransferases.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/75ce97bd5a159a23521f95162ff3973f"><gtr:id>75ce97bd5a159a23521f95162ff3973f</gtr:id><gtr:otherNames>Macauley MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/46D062F5-6685-4872-B510-B94639C94762"><gtr:id>46D062F5-6685-4872-B510-B94639C94762</gtr:id><gtr:title>The minimum information required for a glycomics experiment (MIRAGE) project: improving the standards for reporting glycan microarray-based data.</gtr:title><gtr:parentPublicationTitle>Glycobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d7c92a675b6502a97a707b04cca69bc1"><gtr:id>d7c92a675b6502a97a707b04cca69bc1</gtr:id><gtr:otherNames>Liu Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0959-6658</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2C2B2BD0-E20A-4079-B984-5CD8A7BEFAE2"><gtr:id>2C2B2BD0-E20A-4079-B984-5CD8A7BEFAE2</gtr:id><gtr:title>Glycoproteomic studies of IgE from a novel hyper IgE syndrome linked to PGM3 mutation.</gtr:title><gtr:parentPublicationTitle>Glycoconjugate journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d34dc7692a0ceb7793c3dfcf9922e951"><gtr:id>d34dc7692a0ceb7793c3dfcf9922e951</gtr:id><gtr:otherNames>Wu G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0282-0080</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F35F70B7-39D2-4011-884D-1F008265E4FF"><gtr:id>F35F70B7-39D2-4011-884D-1F008265E4FF</gtr:id><gtr:title>An in vivo functional screen identifies ST6GalNAc2 sialyltransferase as a breast cancer metastasis suppressor.</gtr:title><gtr:parentPublicationTitle>Cancer discovery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/753295004e848e35c2f654a1e17f9d38"><gtr:id>753295004e848e35c2f654a1e17f9d38</gtr:id><gtr:otherNames>Murugaesu N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2159-8274</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EB663278-4D56-4803-9794-1EDB46A35888"><gtr:id>EB663278-4D56-4803-9794-1EDB46A35888</gtr:id><gtr:title>New Helical Binding Domain Mediates a Glycosyltransferase Activity of a Bifunctional Protein.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1bde23452702f3d087e5f35cb87dd0e1"><gtr:id>1bde23452702f3d087e5f35cb87dd0e1</gtr:id><gtr:otherNames>Zhang H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/75F8138E-35DC-40A7-8B8D-A3D8CFE939D1"><gtr:id>75F8138E-35DC-40A7-8B8D-A3D8CFE939D1</gtr:id><gtr:title>Glycosphingolipids on Human Myeloid Cells Stabilize E-Selectin-Dependent Rolling in the Multistep Leukocyte Adhesion Cascade.</gtr:title><gtr:parentPublicationTitle>Arteriosclerosis, thrombosis, and vascular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/74066785fa3c29574f2d9e1f0f818a26"><gtr:id>74066785fa3c29574f2d9e1f0f818a26</gtr:id><gtr:otherNames>Mondal N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1079-5642</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A9CB1948-FA3C-4348-A0F2-ED6AF72F717F"><gtr:id>A9CB1948-FA3C-4348-A0F2-ED6AF72F717F</gtr:id><gtr:title>Gp120 on HIV-1 Virions Lacks O-Linked Carbohydrate.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5501a9167a76e43eb24e466c72c5cd22"><gtr:id>5501a9167a76e43eb24e466c72c5cd22</gtr:id><gtr:otherNames>Stansell E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/13049D2B-D4FE-427D-940C-36562DB8A5DC"><gtr:id>13049D2B-D4FE-427D-940C-36562DB8A5DC</gtr:id><gtr:title>Developing the IVIG biomimetic, hexa-Fc, for drug and vaccine applications.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/be463e4a2b8585bf6dcdae1c2ce8816a"><gtr:id>be463e4a2b8585bf6dcdae1c2ce8816a</gtr:id><gtr:otherNames>Czajkowsky DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/056C8962-29DF-4C73-906C-D42DC1FF0AC2"><gtr:id>056C8962-29DF-4C73-906C-D42DC1FF0AC2</gtr:id><gtr:title>Characterization of the N-glycans of female Angiostrongylus cantonensis worms.</gtr:title><gtr:parentPublicationTitle>Experimental parasitology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4dc10bd7649ddfe24626c91854ab07fb"><gtr:id>4dc10bd7649ddfe24626c91854ab07fb</gtr:id><gtr:otherNames>Ver?ssimo CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0014-4894</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D531FB1D-3B79-45FE-B644-65092F01BD6B"><gtr:id>D531FB1D-3B79-45FE-B644-65092F01BD6B</gtr:id><gtr:title>The Type B Flagellin of Hypervirulent Clostridium difficile Is Modified with Novel Sulfonated Peptidylamido-glycans.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ad5e9a3c71bb147fa1eae321f4fc9a5a"><gtr:id>ad5e9a3c71bb147fa1eae321f4fc9a5a</gtr:id><gtr:otherNames>Bouch? L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D6405138-4F9A-4BE0-8AA4-534F6A55FAF1"><gtr:id>D6405138-4F9A-4BE0-8AA4-534F6A55FAF1</gtr:id><gtr:title>The Cytotoxicity of Elderberry Ribosome-Inactivating Proteins Is Not Solely Determined by Their Protein Translation Inhibition Activity.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9ff3667f369825e5d16cb2cabaf238e5"><gtr:id>9ff3667f369825e5d16cb2cabaf238e5</gtr:id><gtr:otherNames>Shang C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/K016164/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>9BDF80E2-029E-4505-B7EE-DB0FA633E483</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Omic sciences &amp; technologies</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>355E4436-33EB-43B6-9E90-102E2E2280BC</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Glycomics</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>